The functional role of CrkII in actin cytoskeleton organization and mitogenesis

J Biol Chem. 1999 Jan 29;274(5):3001-8. doi: 10.1074/jbc.274.5.3001.

Abstract

Crk is a member of a family of adapter proteins predominantly composed of Src homology 2 and 3 domains, whose role in signaling pathways is presently unclear. Using an in situ electroporation system which permits the introduction of glutathione S-transferase (GST) fusion proteins into cells, we found that c-CrkII bound to p130(cas), but not to paxillin in serum-starved rat-1 fibroblasts overexpressing the human insulin receptor (HIRc cells) in vivo. 17 nM insulin stimulation dissociated the binding of c-CrkII to p130(cas), whereas 13 nM insulin-like growth factor-I, 16 nM epidermal growth factor (EGF), and 10% serum each showed little or no effect. We found that stress fiber formation is consistent with a change in the p130(cas).c-CrkII interactions before and after growth factor stimulation. Microinjection of either GST-Crk-SH2 or -Crk-(N)SH3 domains, or anti-Crk antibody each inhibited stress fiber formation before and after insulin-like growth factor-I, EGF, and serum stimulation. Insulin stimulation by itself caused stress fiber breakdown and there was no additive effect of microinjection. Microinjection of anti-p130(cas) antibody also blocked stress fiber formation in quiescent cells. Microinjection of the Crk-inhibitory reagents also inhibited DNA synthesis after insulin-like growth factor-I, EGF, and serum stimulation, but not after insulin. These data suggest that the complex containing p130(cas).c-CrkII may play a crucial role in actin cytoskeleton organization and in anchorage-dependent DNA synthesis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Actins / physiology*
  • Cells, Cultured
  • Cytoskeleton / drug effects
  • Cytoskeleton / physiology*
  • DNA Replication
  • Electroporation
  • Epidermal Growth Factor / administration & dosage
  • Epidermal Growth Factor / pharmacology
  • Humans
  • Insulin / administration & dosage
  • Insulin / pharmacology
  • Insulin-Like Growth Factor I / administration & dosage
  • Insulin-Like Growth Factor I / pharmacology
  • Microinjections
  • Mitosis
  • Phosphorylation
  • Protein Kinases / physiology*
  • Proto-Oncogene Proteins / metabolism
  • Proto-Oncogene Proteins c-cbl
  • Proto-Oncogene Proteins c-crk
  • Receptor, Insulin / metabolism
  • Recombinant Fusion Proteins / metabolism
  • Signal Transduction
  • Tyrosine / metabolism
  • Ubiquitin-Protein Ligases*
  • src Homology Domains*

Substances

  • Actins
  • Insulin
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-crk
  • Recombinant Fusion Proteins
  • Tyrosine
  • Epidermal Growth Factor
  • Insulin-Like Growth Factor I
  • Proto-Oncogene Proteins c-cbl
  • Ubiquitin-Protein Ligases
  • Protein Kinases
  • Receptor, Insulin
  • CBL protein, human